These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 10079651)
1. New drugs of 1998. Hussar DA J Am Pharm Assoc (Wash); 1999; 39(2):151-206; quiz 289-92. PubMed ID: 10079651 [TBL] [Abstract][Full Text] [Related]
2. New drugs of 1999. Hussar DA J Am Pharm Assoc (Wash); 2000; 40(2):181-221; quiz 323-7. PubMed ID: 10730022 [TBL] [Abstract][Full Text] [Related]
3. New drugs of 2002. Hussar DA J Am Pharm Assoc (Wash); 2003; 43(2):207-45; quiz 246-8, 1 p following 336. PubMed ID: 12688439 [TBL] [Abstract][Full Text] [Related]
4. New drugs of 2000. Hussar DA J Am Pharm Assoc (Wash); 2001; 41(2):229-72. PubMed ID: 11297336 [TBL] [Abstract][Full Text] [Related]
5. New drugs of 2001. Hussar DA J Am Pharm Assoc (Wash); 2002; 42(2):227-63; quiz 263-6. PubMed ID: 11926666 [TBL] [Abstract][Full Text] [Related]
6. New drugs of 2004. Hussar DA J Am Pharm Assoc (2003); 2005; 45(2):185-213; quiz 214-8. PubMed ID: 15868761 [TBL] [Abstract][Full Text] [Related]
7. New drugs of 1997. Hussar DA J Am Pharm Assoc (Wash); 1998; 38(2):155-95; quiz 195-8. PubMed ID: 9654847 [TBL] [Abstract][Full Text] [Related]
8. New drugs of 2003. Hussar DA J Am Pharm Assoc (2003); 2004; 44(2):168-206; quiz 207-10. PubMed ID: 15098851 [TBL] [Abstract][Full Text] [Related]
9. Pediatric information in drug product labeling. Sachs AN; Avant D; Lee CS; Rodriguez W; Murphy MD JAMA; 2012 May; 307(18):1914-5. PubMed ID: 22570457 [No Abstract] [Full Text] [Related]
10. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Wysowski DK; Swartz L Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284 [TBL] [Abstract][Full Text] [Related]
11. Specific Prescribing Information for Geriatric Use in the 2019 Product Labeling for Novel New Drug Approvals. Lisi DM Sr Care Pharm; 2021 Sep; 36(9):455-465. PubMed ID: 34452655 [No Abstract] [Full Text] [Related]
12. The product label: how pharmacokinetics and pharmacodynamics reach the prescriber. Marroum PJ; Gobburu J Clin Pharmacokinet; 2002; 41(3):161-9. PubMed ID: 11929317 [TBL] [Abstract][Full Text] [Related]
13. Availability of information for dosing injectable medications in underweight or obese patients. Jacques KA; Erstad BL Am J Health Syst Pharm; 2010 Nov; 67(22):1948-50. PubMed ID: 21048212 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of drugs in pregnancy. Knoppert D J Popul Ther Clin Pharmacol; 2011; 18(3):e506-12. PubMed ID: 22113261 [TBL] [Abstract][Full Text] [Related]
15. New therapeutic agents marketed in 1993. Hussar DA Pa Med; 1994 Apr; 97(4):12-6. PubMed ID: 8008381 [TBL] [Abstract][Full Text] [Related]
16. Microdosing Studies in Children: A US Regulatory Perspective. Roth-Cline M; Nelson RM Clin Pharmacol Ther; 2015 Sep; 98(3):232-3. PubMed ID: 26095312 [TBL] [Abstract][Full Text] [Related]
17. New therapeutic agents marketed in 1993. Hussar DA Pa Med; 1994 May; 97(5):12-7. PubMed ID: 8036027 [TBL] [Abstract][Full Text] [Related]
18. FDA mulls changes to bioequivalence standards. Traynor K Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205 [No Abstract] [Full Text] [Related]
19. SuperDRUG2: a one stop resource for approved/marketed drugs. Siramshetty VB; Eckert OA; Gohlke BO; Goede A; Chen Q; Devarakonda P; Preissner S; Preissner R Nucleic Acids Res; 2018 Jan; 46(D1):D1137-D1143. PubMed ID: 29140469 [TBL] [Abstract][Full Text] [Related]